Skip to main content
Fig. 6 | Renal Replacement Therapy

Fig. 6

From: Long-term cardiac effect of sacubitril-valsartan in hemodialysis patients with a reduced ejection fraction after aortic valve replacement for aortic stenosis: a case report with literature review

Fig. 6

Changes in the serum N-terminal pro-brain natriuretic peptide levels, hemoglobin, total protein, albumin,, cardiothoracic ratio, body weight and cardiothoracic ratio before and after treatment with sacubitril-valsartan. N = 17. *: dose of erythropoietin-stimulating agents was reduced in 2 patients. **: dose of erythropoietin-stimulating agents was reduced in 4 patients. ***: dose of erythropoietin-stimulating agents was reduced in 6 patients. NT-proBNP, N-terminal pro-brain natriuretic peptide, HD Hemodialysis, BW Body weight

Back to article page